Hope-Fully: A Survivor's Guide to Cancer

Hope-Fully: A Survivor's Guide to Cancer follows oncologist Vincent DeVita as he documents his career in cancer treatment and research. His perspective shifts dramatically when he receives a cancer diagnosis himself, transforming from doctor to patient. DeVita chronicles the evolution of cancer treatment over decades, drawing from his time as director of the National Cancer Institute and as a practicing physician. The narrative alternates between his professional expertise and personal experiences navigating the healthcare system as a patient. Through interviews with colleagues and extensive research, DeVita examines the current state of cancer care while providing context for medical advances. He addresses topics including clinical trials, treatment options, and doctor-patient relationships. The book speaks to fundamental questions about mortality and resilience, exploring the complex intersection between medical knowledge and human experience. Its dual perspective offers insights into both the scientific and emotional dimensions of cancer treatment.

There are not enough internet reviews to create a summary of this book. Instead, here is a summary of reviews of Vincent DeVita's overall work: Readers consistently rate DeVita's most prominent book "The Death of Cancer" (co-written with Elizabeth DeVita-Raeburn) highly for its insider perspective on cancer treatment advances. Many readers appreciate his direct explanations of complex medical concepts and personal stories from his career. What readers liked: - Clear explanations of cancer treatment history and development - Behind-the-scenes look at medical research and drug approval processes - Personal accounts of working with patients - Balance of technical detail and accessible writing What readers disliked: - Some found sections about medical politics and bureaucracy too detailed - A few readers noted an occasionally self-congratulatory tone - Technical terminology can be challenging for non-medical readers Ratings: - Goodreads: 4.3/5 from 856 ratings - Amazon: 4.6/5 from 283 reviews Notable reader comment: "DeVita provides unique insight into how cancer treatment evolved, though sometimes gets bogged down in institutional politics." - Goodreads reviewer

When Breath Becomes Air by Paul Kalanithi A neurosurgeon's memoir chronicles his transformation from doctor to terminal cancer patient while exploring questions of mortality and meaning.

The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee This medical history combines scientific research with personal narratives to tell the story of cancer and humanity's battle against it.

The Bright Hour: A Memoir of Living and Dying by Nina Riggs A descendant of Ralph Waldo Emerson documents her journey through breast cancer with observations about family, legacy, and time.

Between Two Kingdoms: A Memoir of a Life Interrupted by Suleika Jaouad A cancer survivor recounts her diagnosis at age twenty-two, her treatment journey, and her cross-country road trip to reconnect with life.

The Unwinding of the Miracle by Julie Yip-Williams A terminal cancer diagnosis prompts a blind immigrant lawyer to reflect on her extraordinary life journey from Vietnam to Harvard to motherhood.

📚 Vincent DeVita served as director of the National Cancer Institute from 1980 to 1988, leading some of the most significant advances in cancer treatment during his tenure. 🔬 The book shares DeVita's deeply personal journey as both a pioneering oncologist and a cancer patient himself, offering a unique dual perspective on the disease. 💉 DeVita helped develop the first successful combination chemotherapy treatment, MOPP, which revolutionized the treatment of Hodgkin's lymphoma and increased survival rates dramatically. 🏥 The author's experience treating his own daughter, who was diagnosed with breast cancer, influenced his views on patient advocacy and the importance of seeking second opinions. 🔍 Throughout the book, DeVita emphasizes how cancer treatment has evolved from being almost universally fatal in the 1950s to having cure rates of over 70% for many types of cancer today.